https://orcid.org/0000-0003-2089-6054
Contact me about:
Learn more about the Get the Inside Track on NIH Changes series in April, the new Open Access Policy for the Gates Foundation, and support for Article Processing Charges.
Learn more about the new ICMJE recommendations, Highly Cited Researchers from Clarivate, and Public Domain Day.
Learn more about Open October, and the Common Forms for Biographical Sketch and Current and Pending (Other) Support for NIH, SciENcv, and ORCID.
Learn more about retractions, the draft NIH Public Access Policy for publications and the new release of Journal Citation Reports (JCR).
Learn more about SciENcv and using ORCID to build the new NSF biographical sketch, the new Elsevier Transformative Agreement, and the revised Public Access Policy for the Gates Foundation.
Learn more about policy changes for Journal Citation Reports, new website pages for the NIH Public Access Policy, and the Papermill Detection service from Wiley.
This is the second of a three-part series on Artificial Intelligence (AI) in biomedicine. Part I introduced readers to the basics of AI and Part III will focus on authorship issues related to AI and publishing.
Learn more about the updated ICMJE Recommendations, the December 2023 NSF notice on Artificial Intelligence, and a new video on using SciENcv for NSF biosketches.
Learn more about the recommendations from ICJME for authors and AI, the Highly Cited Researchers list for 2023, the new Article Development Charge from the American Chemical Society, and a new video that helps researchers assess journal quality. Authors and AI The ICJME Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in [Read more]
This is the first of a three-part series on Artificial Intelligence (AI) in biomedicine. Part I includes an introduction to AI, its definitions, WashU announcements and policies, and resources; Part II will provide an overview of select AI tools for scholarly literature; and Part III will focus on authorship issues related to AI and publishing. [Read more]